U.S. Health Care REITs Stock News

NasdaqCM:PLUG
NasdaqCM:PLUGElectrical

Is Plug Power’s (PLUG) Big Boost In Authorized Shares Quietly Rewriting Its Capital Strategy?

In February 2026, Plug Power Inc. shareholders approved a charter amendment to increase authorised common stock from 1.50 billion to 3.00 billion shares, effective February 12 following filing in Delaware. This expanded share capacity gives Plug Power more room to raise equity capital, refinance obligations, and fund operations during a leadership transition from CEO Andy Marsh to Jose Luis Crespo. Next, we will examine how this substantial expansion of authorised shares could influence Plug...
NYSE:MMM
NYSE:MMMIndustrials

Assessing 3M (MMM) Valuation After Mixed Momentum And A 6% Undervalued Fair Value Estimate

3M stock at a glance 3M (MMM) has been drawing attention after recent share price moves, with the stock closing at $167.62 and short term returns mixed across the past week, month, and past 3 months. See our latest analysis for 3M. Recent trading has been choppy, with a 1 day share price return of a 2.44% decline and a modest 3.58% share price return year to date. The 1 year total shareholder return of 14.58% and 3 year total shareholder return of just over 2x suggest longer term holders have...
NasdaqGS:INTU
NasdaqGS:INTUSoftware

Is Intuit (INTU) Using the Wix Deal to Quietly Redefine Its Small‑Business Platform Strategy?

Earlier this month, Wix.com Ltd. and Intuit Inc. expanded their partnership, allowing millions of Wix users to integrate Intuit’s QuickBooks Online AI-powered financial tools directly with Wix’s website and ecommerce platform. This collaboration deepens Intuit’s ecosystem reach by embedding its financial management and AI capabilities inside Wix’s online business workflows, potentially increasing the appeal and stickiness of Intuit’s small-business offerings. Next, we’ll examine how...
NYSE:DHR
NYSE:DHRLife Sciences

Is Danaher (DHR) Attractive After Recent Share Price Weakness?

If you are wondering whether Danaher at around US$206 per share still offers good value, you are not alone. The answer depends on how you look at its underlying business and valuation. The stock has recently been under pressure, with a 6.1% decline over the last week, a 12.6% decline over the last month and a 10.4% decline year to date, although the 1 year return sits at 1.5%. These moves sit against a backdrop of ongoing interest in large, diversified life sciences and diagnostics...
NYSE:ACM
NYSE:ACMConstruction

Does AECOM’s (ACM) TomTom Deal Quietly Redefine Its Consulting-Led, Digital-First Strategy?

In recent days, AECOM reported first-quarter 2026 results showing lower sales and net income year over year, completed a multi-year US$3.14 billion share repurchase program, secured new design work on Sydney Metro West in joint venture with WSP, and entered a new global mobility and infrastructure planning partnership announced by TomTom. These developments highlight AECOM’s focus on higher-value consulting and digital capabilities, while continued buybacks and raised 2026 earnings guidance...
NYSE:CHWY
NYSE:CHWYSpecialty Retail

Chewy Leans On Autoship As Pet Services Shift Meets Weak Share Price

Chewy (NYSE:CHWY) is pushing further into pet healthcare, insurance, and advertising as new business lines. The company is leaning on its Autoship subscription program to deepen customer loyalty and support these services. This combination of higher margin offerings and recurring revenue is reshaping how Chewy positions itself in the pet market. Chewy enters this shift with its shares at $23.8, after a 37.5% decline over the past year and a 78.3% decline over the past five years. The stock...
NYSE:CAT
NYSE:CATMachinery

Caterpillar RPMGlobal Deal Deepens Mining Software And Services Focus

Caterpillar has completed its acquisition of mining software company RPMGlobal, expanding its mining technology and planning tools. The deal adds advanced data, scheduling and site management capabilities to Caterpillar's existing mining equipment and digital offerings. The move supports Caterpillar's push to offer more integrated, software driven solutions to mining customers. Caterpillar, traded as NYSE:CAT, now has RPMGlobal's mining software portfolio alongside its existing hardware and...
NYSE:S
NYSE:SSoftware

Is There Now An Opportunity In SentinelOne (S) After A 45% One Year Share Price Fall

If you are wondering whether SentinelOne's current share price reflects its true worth, this article will walk through what the numbers are really saying about the stock. After its last close at US$13.40, SentinelOne's returns sit at a 2.4% decline over 7 days, a 3.6% decline over 30 days, an 8.5% decline year to date, and a 45.0% decline over the past year, with a 12.5% decline over 3 years. Recent coverage of SentinelOne has focused on its position in cybersecurity and how investor...
NYSE:PHIN
NYSE:PHINAuto Components

What PHINIA (PHIN)'s Strong 2025 Results and 2026 Outlook Means For Shareholders

In February 2026, PHINIA Inc. reported that fourth-quarter 2025 sales rose to US$889 million with net income of US$45 million, while full-year 2025 sales reached US$3.48 billion and net income climbed to US$130 million, alongside higher diluted earnings per share from continuing operations for both periods versus the prior year. The company also issued 2026 guidance calling for net sales of US$3.52 billion to US$3.72 billion and higher projected net earnings, reinforcing investor attention...
NYSE:FRT
NYSE:FRTRetail REITs

A Look At Federal Realty (FRT) Valuation After Earnings Beat Guidance And Dividend Affirmation

Why Federal Realty Investment Trust (FRT) Is In Focus After Its Latest Earnings Federal Realty Investment Trust (FRT) has drawn fresh attention after reporting fourth quarter and full year 2025 results, issuing 2026 earnings guidance, and affirming regular common and preferred dividends on the same day. See our latest analysis for Federal Realty Investment Trust. The earnings beat, fresh 2026 guidance and confirmation of both common and preferred dividends come as Federal Realty Investment...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

Clinical Hold Lift On MAGNITUDE-2 Resets Risk Reward For Intellia Investors

Regulators have lifted the clinical hold on Intellia Therapeutics' MAGNITUDE-2 study, allowing the gene editing trial to resume. The decision follows updates to safety protocols after rare adverse events were evaluated. The cleared pathway enables expanded enrollment for MAGNITUDE-2 and continued work on Intellia's in vivo gene editing program. For you as an investor looking at Intellia Therapeutics (NasdaqGM:NTLA), this regulatory step comes as the stock trades at $12.22. The share price...
NasdaqGS:ROAD
NasdaqGS:ROADConstruction

The Bull Case For Construction Partners (ROAD) Could Change Following Raised 2026 Guidance And Buybacks - Learn Why

Construction Partners, Inc. recently reported first-quarter 2026 results showing sales of US$809.47 million and net income of US$17.21 million, and it raised full-year fiscal 2026 revenue and net income guidance while also completing a US$22.94 million share repurchase program announced in April 2024. Alongside these financial updates, the company’s participation at the Barclays 43rd Annual Industrial Select Conference in Miami in February 2026 gave management an additional platform to...
NYSE:DE
NYSE:DEMachinery

Has Deere (DE) Run Too Far After 29% Year To Date Surge?

Wondering whether Deere at around US$600 a share still offers fair value, or if the price has already run too far ahead of the fundamentals? This article is built to help you answer that question calmly and clearly. The stock last closed at US$600.84, with returns of 1.3% over 7 days, 16.8% over 30 days, 28.7% year to date, 21.4% over 1 year, 46.7% over 3 years, and 90.1% over 5 years. This naturally raises questions about what is already priced in and how much risk is now on the...
NYSE:EPAM
NYSE:EPAMIT

EPAM Expands Empathy Lab AI Agency As Share Price Lags Targets

EPAM Systems (NYSE:EPAM) has launched Empathy Lab, an AI native agency, in North America. The move follows the earlier roll out of Empathy Lab in Europe and is aimed at helping brands modernize marketing and technology using AI. EPAM has appointed Ben Hall as Head of Empathy Lab for North America to lead the expansion. EPAM Systems is rolling out this new AI focused offering at a time when its share price is around $162.2 and recent returns have been weak. The stock shows a 15.3% decline...
NasdaqGS:EQIX
NasdaqGS:EQIXSpecialized REITs

Equinix Lagos Data Center Investment Tied To Valuation And Momentum

Equinix is investing $22 million in a new LG3 data center in Lagos, Nigeria. The Lagos build out expands the company’s presence in Africa as part of its broader regional plan. The project is aimed at supporting rising demand for digital infrastructure and connectivity across the continent. For investors watching NasdaqGS:EQIX, the Lagos investment comes alongside a share price of $951.97 and reported recent returns of 11.1% over the past week, 18.7% over the past month, and 24.6% year to...
NYSE:AB
NYSE:ABCapital Markets

AllianceBernstein Initiatives In Research And Tech Set Against Valuation Concerns

AllianceBernstein Holding (NYSE:AB) has entered a new joint venture with Societe Generale to build out global research capabilities. The firm is expanding further into private alternatives with capital support from EQH. AllianceBernstein has also signed a multi year partnership with SimCorp to upgrade its investment technology and data infrastructure. For investors watching NYSE:AB, these moves sit alongside a recent share price of $41.43 and multi year total returns of 21.9% over 1 year,...
NasdaqCM:ATOM
NasdaqCM:ATOMSemiconductor

A Look At Atomera (ATOM) Valuation After GAA MST Breakthroughs And New OEM Partnership

Atomera (ATOM) is back on investors’ radar after reporting fourth quarter and full year 2025 results that highlight very small current sales, continued losses, and ongoing investment in its Mears Silicon Technology platform. See our latest analysis for Atomera. The latest earnings release and technical updates landed alongside a sharp shift in sentiment, with a 46.17% 1 day share price return and a 142.80% year to date share price return contrasting with a 5 year total shareholder return...
NYSE:OXY
NYSE:OXYOil and Gas

Occidental Petroleum OxyChem Sale Reshapes Debt Profile And Shareholder Returns

Occidental Petroleum agreed to sell its OxyChem business for $9.7 billion, marking a major reshaping of its portfolio. The transaction is expected to affect the company’s balance sheet, debt mix, and capital return plans once completed. Investors are watching how proceeds from the sale could influence future buybacks, dividends, and overall financial flexibility. For investors tracking NYSE:OXY, this move comes at a time when the shares trade around $45.94 and the longer-term record has...
NYSE:STT
NYSE:STTCapital Markets

What State Street (STT)'s New Prime Money Market ETF and Mariner Deal Mean For Shareholders

In February 2026, State Street Corporation announced that Mariner will adopt Charles River’s Wealth Management Solution to support its goal of scaling from more than 2,080 advisors toward 5,000 while centralizing portfolio management, trading, data integration, and advisor workflows. State Street Investment Management also launched the actively managed State Street Prime Money Market ETF (ticker: MMK), a low-cost prime cash vehicle drawing on its cash team’s US$599.55 billion in assets...
NasdaqGS:KLIC
NasdaqGS:KLICSemiconductor

Assessing Whether Kulicke And Soffa (KLIC) Shares Look Overvalued After Their Recent Strong Run

Why Kulicke and Soffa Industries (KLIC) Is On Investors’ Radar Kulicke and Soffa Industries (KLIC) has drawn fresh attention after a strong past 3 months for the stock, with recent trading around $71.77 prompting investors to reassess its valuation and fundamentals. See our latest analysis for Kulicke and Soffa Industries. While the share price is around $71.77 after a 24.71% 1 month share price return and 103.37% 3 month share price return, the 72.18% 1 year total shareholder return suggests...
NasdaqGS:PPC
NasdaqGS:PPCFood

Assessing Pilgrim's Pride (PPC) Valuation After Earnings Miss And 2026 Expansion Plan

Pilgrim's Pride (PPC) is back in focus after reporting fourth quarter 2025 earnings, with higher sales and softer margins, plus a sizable 2026 capex plan aimed at prepared foods capacity and operational efficiencies. See our latest analysis for Pilgrim's Pride. The latest earnings release and 2026 capex plan come after a period of firm momentum in the shares, with a 30 day share price return of 5.10% and a 90 day share price return of 15.61%. This is the case even though the 1 year total...
NYSE:TE
NYSE:TEElectrical

Assessing T1 Energy (TE) Valuation After Sudden Chief Accounting Officer Transition

Why this leadership change at T1 Energy (TE) is on investors’ radar T1 Energy (TE) just made an abrupt change in a key finance role, with the immediate departure of Chief Accounting Officer and Corporate Controller Denise Cruz and the same-day appointment of Tom Mahrer. Because this position oversees accounting policy and financial reporting, any sudden shift can draw investor focus to how the company’s numbers are produced, audited, and communicated to the market. See our latest analysis for...
NasdaqCM:MARA
NasdaqCM:MARASoftware

MARA Holdings Faces Rising Short Interest As Earnings Estimates Improve

Short interest in MARA Holdings (NasdaqCM:MARA) has recently moved sharply higher, now sitting well above levels seen in many peers. Analysts have turned more cautious on the stock, citing sector risks and increased insider selling activity. The shift in positioning comes even as some earnings estimates for MARA Holdings have been revised upward. MARA Holdings, listed on NasdaqCM under the ticker MARA, has attracted fresh attention as investor positioning has turned more bearish. The...
NasdaqGS:TWST
NasdaqGS:TWSTBiotechs

Twist Bioscience Expands Antibody And Genomics Tools As Valuation Stays Stretched

Twist Bioscience (NasdaqGS:TWST) agreed to license Invenra’s B-Body bispecific antibody platform on a co exclusive basis, while also taking an equity stake and a board seat in Invenra. The company also introduced new advanced library preparation kits aimed at next generation sequencing and clinical research customers. For you as an investor, these moves sit at the intersection of antibody discovery and genomics tools, which is where Twist Bioscience has been building its business. The tie...